UnitedHealth Group Incorporated announced unaudited consolidated earnings results for the quarter and year ended December 31, 2017. For the quarter, the company reported total revenues of $52,061 million compared to $47,535 million a year ago. Earnings from operations was $3,977 million compared to $3,187 million a year ago. Earnings before income taxes was $3,669 million compared to $2,919 million a year ago. Net earnings was $3,721 million compared to $1,708 million a year ago. Earnings per diluted share attributable to common shareholders was $3.65 compared to $1.74 a year ago. Adjusted net earnings attributable to common shareholders was $2,562 million compared to $2,043 million a year ago. Adjusted earnings per diluted share was $2.59 compared to $2.11 a year ago.

For the year end, the company reported total revenues of $201,159 million compared to $184,840 million a year ago. Earnings from operations was $15,209 million compared to $12,930 million a year ago. Earnings before income taxes was $14,023 million compared to $11,863 million a year ago. Net earnings was $10,823 million compared to $7,073 million a year ago. Earnings per diluted share attributable to common shareholders was $10.72 compared to $7.25 a year ago. Cash flows from operating activities was $13,596 million compared to $9,795 million a year ago. Adjusted net earnings attributable to common shareholders was $9,923 million compared to $7,795 million a year ago. Adjusted earnings per diluted share was $10.07 compared to $8.05 a year ago.

The company revised its earnings guidance for the year 2018. For the period, the company expects net earnings of $11.65 to $11.95 per share and adjusted net earnings of $12.30 to $12.60 per share. Cash flows from operations are expected to range from $15 billion to $15.5 billion. The company expects depreciation and amortization in the range of $2,350 million – $2,400 million, EBITDA in the range of $19,050 million – $19,700 million, interest expense in the range of $1,200 million – $1,250 million, tax rate of 24%, net earnings attributable to UnitedHealth Group Shareholders in the range of $11,475 million – $11,775 million and capital expenditures of $2,000 million. The company expects adjusted net earnings attributable to UnitedHealth Group common shareholders in the range of $12,100 million to $12,400 million, GAAP net earnings in the range of $11,800 million to $12,200 million, revenue in the range of $223,000 million - $225,000 million, Earnings from operations in the range of $16,700 million – $17,300 million.